Home › Research › Risk factors
Diabetes status, duration, and risk of dementia among ischemic stroke patients
Jonguk Kim, Kyungdo Han, Jeong‐Yoon Lee, Ye Yang, Dae Young Cheon, Jaejun Lee, Minwoo Lee. Alzheimer s Research & Therapy, 2025-03-08
Topic: Risk, prevention and care in population studies
Plain-language summary
Among 118,790 participants (average age 64.26 ± 9.95 years, 48% male), 16.7% developed dementia during an average follow-up of 7.3 ± 2.3 years. Participants with a history of T2DM for less than five years at cohort entry had a 26.7% higher risk of developing all-cause dementia compared to those with normoglycemia. Those with T2DM for five years or longer had a 46.7% increased risk, with an adjusted hazard ratio (aHR) of 1.466 (95% confidence interval [CI], 1.408-1.527). Specifically, the risk of developing Alzheimer's disease (AD) and vascular dementia (VaD) rose by 43.4% and 51.4%, respectively, for individuals with T2DM lasting more than five years (aHR 1.434, 95% CI 1.366-1.505; aHR 1.514, 95% CI 1.365-1.679, respectively). Our findings demonstrated a significant association between an extended duration of T2DM and an increased risk of developing all-cause dementia, including AD and VaD in post-stroke population. These results emphasize proactive dementia prevention approaches in stroke survivors, particularly those with longstanding T2DM.
What this study adds
Evidence grade: Moderate
The record lists 118,790 participants. Among 118,790 ischemic stroke patients followed for an average of 7.3 years, those with type 2 diabetes for five years or longer had a 46.7% higher risk of all-cause dementia, with increased risks of Alzheimer's disease and vascular dementia. Reported effect size: 16.7%; 26.7%; 46.7%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Kim, J., Han, K., Lee, J., Yang, Y., Cheon, D. Y., Lee, J., et al. (2025). Diabetes status, duration, and risk of dementia among ischemic stroke patients. Alzheimer s Research & Therapy. https://doi.org/10.1186/s13195-025-01708-8
Vancouver
Kim J, Han K, Lee J, Yang Y, Cheon DY, Lee J, et al. Diabetes status, duration, and risk of dementia among ischemic stroke patients. Alzheimer s Research & Therapy. 2025. doi:10.1186/s13195-025-01708-8. PMID: 40057772.
BibTeX
@article{kim2025-40057772,
author = {Kim, Jonguk and Han, Kyungdo and Lee, Jeong‐Yoon and Yang, Ye and Cheon, Dae Young and Lee, Jaejun and Lee, Minwoo},
title = {{Diabetes status, duration, and risk of dementia among ischemic stroke patients}},
journal = {Alzheimer s Research \& Therapy},
year = {2025},
doi = {10.1186/s13195-025-01708-8},
pmid = {40057772},
url = {https://doi.org/10.1186/s13195-025-01708-8}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Among 118,790 participants (average age 64.26 ± 9.95 years, 48% male), 16.7% developed dementia during an average follow-up of 7.3 ± 2.3 years.
- Participants with a history of T2DM for less than five years at cohort entry had a 26.7% higher risk of developing all-cause dementia compared to those with normoglycemia.
- Those with T2DM for five years or longer had a 46.7% increased risk, with an adjusted hazard ratio (aHR) of 1.466 (95% confidence interval [CI], 1.408-1.527).
- Specifically, the risk of developing Alzheimer's disease (AD) and vascular dementia (VaD) rose by 43.4% and 51.4%, respectively, for individuals with T2DM lasting more than five years (aHR 1.434, 95% CI 1.366-1.505; aHR 1.514, 95% CI 1.365-1.679, respectively).
- Our findings demonstrated a significant association between an extended duration of T2DM and an increased risk of developing all-cause dementia, including AD and VaD in post-stroke population.
Why it matters
Among 118,790 ischemic stroke patients followed for an average of 7.3 years, those with type 2 diabetes for five years or longer had a 46.7% higher risk of all-cause dementia, with increased risks of Alzheimer's disease and vascular dementia. The findings support proactive dementia prevention in stroke survivors with longstanding type 2 diabetes, but the study did not test whether any treatment prevents or cures dementia.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Participants118,790
- Effect size16.7%; 26.7%; 46.7%
- Evidence strengthModerate
How this study scored 52/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s Research & Therapy) |
| Journal's citation record | 1 / 4 | Alzheimer s Research & Therapy: journal h-index 146 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 4 / 4 | 118,790 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 10 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 3.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 6.4× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 1 / 4 | Cited 10 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Minwoo Lee: h-index 24 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Seoul National University: institution h-index 1,053 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 10 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40057772) |
| Free to read | 2 / 2 | Free to read |
| Total | 52 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1186/s13195-025-01708-8
- PubMed: 40057772
- Original source →
- Free full text: Alzheimer s Research & Therapy →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Risk factors from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.